Advent Capital Management Bristol Myers Squibb CO Transaction History

Advent Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $1.31 Million - $1.49 Million	20,000 New	20,000 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $2.54 Million - $2.8 Million	-35,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.88 Million - $2.19 Million	35,000 New	35,000 $2.18 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $808,480 - $1.01 Million	-16,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $958,720 - $1.1 Million	16,000 New	16,000 $1.01 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.